Exploring the Impact of Bevacizumab Injection in Advanced Cancer Treatment
Bevacizumab is a recombinant monoclonal antibody that blocks the growth of new blood vessels (angiogenesis). It is often used in the treatment of various advanced cancers. It is developed to prevent the growth of tumors. It is indicated along with other chemotherapy drugs to treat metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, and colorectal cancer. It is also used to treat cancers of the ovary, fallopian tube, or primary peritoneal cancer. It is not recommended for children under the age of 18. How Does Bevacizumab work It is a recombinant humanized monoclonal antibody that works as a targeted therapy in the treatment of various advanced cancers. It produces its action by selectively binding to the protein called vascular endothelial growth factor A (VEGF-A), which is present in the lining of blood and lymph vessels in the body. It interrupts the interaction of VEGF-A with its receptors. This further inhibits the formation of blood vessels that su...